Cargando…

Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination

KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Hsiang‐Chiun, Chen, Hsin‐Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182003/
https://www.ncbi.nlm.nih.gov/pubmed/37192849
http://dx.doi.org/10.1002/ccr3.7342
_version_ 1785041697237893120
author Teng, Hsiang‐Chiun
Chen, Hsin‐Hsu
author_facet Teng, Hsiang‐Chiun
Chen, Hsin‐Hsu
author_sort Teng, Hsiang‐Chiun
collection PubMed
description KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.
format Online
Article
Text
id pubmed-10182003
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101820032023-05-14 Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination Teng, Hsiang‐Chiun Chen, Hsin‐Hsu Clin Case Rep Case Report KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment. John Wiley and Sons Inc. 2023-05-12 /pmc/articles/PMC10182003/ /pubmed/37192849 http://dx.doi.org/10.1002/ccr3.7342 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Teng, Hsiang‐Chiun
Chen, Hsin‐Hsu
Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title_full Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title_fullStr Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title_full_unstemmed Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title_short Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
title_sort platelet‐rich plasma in the treatment of alopecia areata after covid‐19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182003/
https://www.ncbi.nlm.nih.gov/pubmed/37192849
http://dx.doi.org/10.1002/ccr3.7342
work_keys_str_mv AT tenghsiangchiun plateletrichplasmainthetreatmentofalopeciaareataaftercovid19vaccination
AT chenhsinhsu plateletrichplasmainthetreatmentofalopeciaareataaftercovid19vaccination